Type 2 diabetes is one of the most common long-term health problems in the world. Millions of people live with this condition every day.
It happens when the body cannot properly use insulin, a hormone that helps move sugar from the blood into the body’s cells for energy. Over time, the body may also stop making enough insulin.
As a result, sugar builds up in the blood instead of being used by the body. High blood sugar can slowly damage important organs and increase the risk of heart disease, kidney disease, nerve damage, vision problems, and other serious health conditions.
For many people with Type 2 diabetes, the first medicine doctors prescribe is metformin. This drug has been used for many years and is known for helping lower blood sugar levels safely and effectively. Metformin works mainly by reducing the amount of sugar made by the liver and helping the body respond better to insulin.
In the early stages of diabetes, metformin often works very well. However, Type 2 diabetes usually changes over time. Many patients eventually find that metformin alone is no longer enough to keep their blood sugar under control.
Because of this, researchers around the world are searching for better treatments that can work for longer periods and provide extra health benefits. A team of scientists at Thomas Jefferson University has now reported encouraging results from a major study involving two diabetes drugs called dapagliflozin and exenatide.
Their findings suggest that using these medicines together may offer stronger and longer-lasting blood sugar control than using either medicine alone.
The research included 695 adults with Type 2 diabetes whose blood sugar levels were still too high even though they were already taking metformin. The scientists divided the participants into three treatment groups.
One group received weekly injections of exenatide together with metformin. Another group took daily dapagliflozin pills with metformin. The third group received both dapagliflozin and exenatide in addition to metformin.
The results were very promising. Patients who received the combination of both drugs had better control of their blood sugar than those who took only one of the medicines.
Even more importantly, the improvements lasted during the entire two-year study period. This is especially important because many diabetes treatments become less effective over time.
The two drugs help the body in different ways. Dapagliflozin belongs to a newer group of diabetes medicines known as SGLT2 inhibitors. It works through the kidneys by helping the body remove extra sugar through urine. By getting rid of excess sugar, blood sugar levels can fall naturally.
Exenatide works differently. It belongs to a group of drugs called GLP-1 receptor agonists. This medicine helps the body release more insulin after meals, lowers the amount of sugar made by the liver, slows digestion, and helps people feel full for a longer time after eating.
These effects can also help patients lose weight, which is very important for many people with Type 2 diabetes. Carrying extra body weight can make it harder for the body to control blood sugar.
In addition, the study found that the drug combination also helped lower blood pressure, another important health benefit because many people with diabetes also struggle with heart and blood vessel problems.
One reason doctors are interested in combining medicines like these is because Type 2 diabetes is a complex disease. A single drug may target only one problem inside the body, while a combination of medicines can work on several different problems at the same time.
By using dapagliflozin and exenatide together, patients may gain the benefits of both treatments without needing extremely high doses of either one.
Safety is another major concern when adding more medicines to a treatment plan. The researchers reported that no unexpected side effects appeared during the study. This suggests the combination treatment was not only effective but also reasonably safe for the participants involved in the research.
The study was led by Dr. Serge Jabbour at Thomas Jefferson University and was published in the medical journal Diabetes Care. The findings add to growing evidence that newer combination therapies may improve long-term diabetes management and help patients maintain healthier blood sugar levels for years.
Doctors say good diabetes control is important because it can reduce the risk of severe complications later in life. Keeping blood sugar levels stable may help protect the heart, kidneys, eyes, and nerves.
Researchers also hope that newer treatments can improve quality of life by helping patients manage weight and blood pressure at the same time.
Although more studies may continue to explore the long-term benefits of these medications, this research offers new hope for people who are struggling to manage their diabetes with metformin alone.
It also shows how modern diabetes treatment is moving toward more personalized care, where doctors can combine different medicines to better match each patient’s needs.
Anyone living with Type 2 diabetes should speak with their doctor before changing medications or starting new treatments. Diabetes care plans should always be based on personal health needs and medical advice.
Still, studies like this show that better treatment options continue to emerge, giving patients more ways to protect their health and live longer, healthier lives.
If you care about diabetes, please read studies about Vitamin D and type 2 diabetes, and to people with diabetes, some fruits are better than others.
For more health information, please see recent studies that low calorie diets may help reverse diabetes, and 5 vitamins that may prevent complication in diabetes.
Copyright © 2026 Knowridge Science Report. All rights reserved.
